ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2912

The Neural Correlates of Inflammation in RA: A Multi-Modal MRI Study

Andrew Schrepf1, Chelsea Cummiford1, Eric Ichesco1, Tony Larkin1, Steven E. Harte1, Richard E. Harris1, Alison Murray2, Gordon Waiter3, Daniel J. Clauw4 and Neil Basu5, 1Chronic Pain and Fatigue Research Center, University of Michigan, Ann Arbor, MI, 2Aberdeen Brain Imaging Center, University of Aberdeen, Aberdeen, United Kingdom, 3Aberdeen Brain Imaging Centre, University of Aberdeen, Aberdeen, United Kingdom, 4Chronic Pain & Fatigue Research Center, University of Michigan, Ann Arbor, MI, 5Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Fatigue, inflammation and rheumatoid arthritis (RA), MRI

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, November 8, 2017

Title: Rheumatoid Arthritis – Clinical Aspects VI: Comorbidities of Rheumatoid Arthritis

Session Type: ACR Concurrent Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose:

Inflammation is the hallmark of disease activity in rheumatoid arthritis (RA). RA is characterized by fatigue and cognitive/affective disturbances, and these symptoms often worsen during a disease flare. However, surprisingly little is known about the neural correlates of inflammation in autoimmune disease. Here we used MRI to investigate how neuroimaging outcomes are associated with levels of peripheral inflammation in this patient population.

Methods: RA patients, fulfilling ACR/EULAR 2012 criteria, were recruited and underwent a multi-modal MRI brain scan which was repeated 6 months later to validate our findings. Recruitment was stratified (1:1) by disease activity (swollen joint count ≥1). The clinical evaluation included measures of inflammation (ESR) and self-reported levels of fatigue and pain (VAS) as well as depression (Hospital Anxiety and Depression Scale). Images were acquired by a 3 Tesla, 8 channel phased array head coil using a T2*-weighted gradient-echo echo-planar imaging pulse sequence. Functional connectivity was assessed during a simple cognitive task and conducted through Independent Components Analysis (ICA) to investigate the relationship of established neural networks with other brain regions. Structural analyses were conducted using voxel-based morphometry (VBM). The primary outcomes of interest were brain regions where connectivity varied with levels of ESR. These regions were then examined post-hoc for associations with VBM findings, and clinical symptoms. Primary results were significant on the cluster level with a false discovery rate (FDR) p value <0.05 derived from an uncorrected voxel level p value <0.001.

Results: Fifty-four subjects participated (mean age 54.9 years; 75.9% female; mean disease duration 11.5 years; mean ESR 19.4 [2-62]; mean DAS28 3.6 [range 1.5-6.4]). Several regions were identified that showed positive connections to the Dorsal Attention Network (DAN), Salience Network (SLN), and Default Mode Network (DMN) as ESR increased. The right (R) frontal pole (r= .56, p=.002 FDR), and left (L) inferior/superior parietal junction (r=.58, p=.001) showed positive connections to the DAN while the L inferior parietal lobule, L mid-temporal gyrus and several frontal regions, demonstrated positive connections to the DMN and SLN (all p < .05 FDR). Positive connections between the R frontal pole and L parietal with the DAN were replicated at the second time point (p<.05). In the same parietal region, higher inflammation was associated with decreased grey matter volume. The degree of connectivity in most of the identified regions was associated with more severe fatigue and pain scores.

Conclusion: The neurobiology of fatigue, cognitive dysfunction, and pain in RA, and their relationship with inflammation are poorly understood, yet these are some of the most common and debilitating symptoms in rheumatic diseases. The present study identified brain regions that may serve as inflammatory “hubs” in RA. Several of these regions play important roles in higher-order cognitive processing and therefore may represent key areas underpinning the development of symptoms such as fatigue and cognitive impairment in RA.


Disclosure: A. Schrepf, None; C. Cummiford, None; E. Ichesco, None; T. Larkin, None; S. E. Harte, None; R. E. Harris, None; A. Murray, None; G. Waiter, None; D. J. Clauw, Abbott Pharmaceutical, 5,Aptinyx, 5,Astellas Phamaceutical, 5,Cerephex, 5,Daiichi Sankyo, 5,Pfizer Inc, 5,Pierre Fabre, 8,Samumed, 5,Theravance, 5,Tonix, 5; N. Basu, None.

To cite this abstract in AMA style:

Schrepf A, Cummiford C, Ichesco E, Larkin T, Harte SE, Harris RE, Murray A, Waiter G, Clauw DJ, Basu N. The Neural Correlates of Inflammation in RA: A Multi-Modal MRI Study [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/the-neural-correlates-of-inflammation-in-ra-a-multi-modal-mri-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-neural-correlates-of-inflammation-in-ra-a-multi-modal-mri-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology